A pilot pharmacokinetic and immunoscintigraphic study with the Technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors

Cancer

Volumn 80, Issue 12 SUPPL., 1997, Pages 2484-2489

  Mariani, Giuliano ^a   Lasku, Arben ^a   Pau, Antonio ^a   Villa, Giuseppe ^a   Motta, Cinzia ^a   Calcagno, Giuseppina ^a   Taddei, Gioconda Z ^a   Castellani, Patrizia ^b   Syrigos, Kostas ^c   Dorcaratto, Alessandra ^a   Epenetos, Agamennon A ^c   Zardi, Luciano ^b   Viale, Giuseppe A ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Brain tumors; Immunoscintigraphy; Monoclonal antibody; Oncofetal fibronectin; Radiopharmacokinetics

Indexed keywords

FIBRONECTIN; MEDRONATE TECHNETIUM TC 99M; MONOCLONAL ANTIBODY TC 99M; ONCOFETAL ANTIGEN; PENTETATE TECHNETIUM TC 99M;

ADULT; BRAIN CANCER; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; FEMALE; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSCINTIGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; MALIGNANT MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 0031456939     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1097-0142(19971215)80:12+<2484::aid-cncr20>3.0.co;2-7     Document Type: Conference Paper

References (17)

1. Mariani G, Lasku A, Balza E, Gaggero B, Motta C, Di Luca L, et al. Tumor targeting potential of the monoclonal antibody BC-1 against oncofetal fibronectin in nude mice bearing human tumor implants. Cancer 1997;80:2378-84.
2. Norton PA, Hynes RO. Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells. Mol Cell Biol 1987;7:4297-307.
3. Zardi L, Carnemolla B, Siri A, Petersen TE, Paolella G, Sebastio G, et al. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J 1987;6:2337-42.
4. Carnemolla B, Balza E, Siri A, Zardi L, Nicotra MR, Bigotti A, et al. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors. J Cell Biol 1989;108:1139-48.
5. Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol 1989;109:903-14.
6. Borsi L, Balza E, Allemanni G, Zardi L. Differential expression of the fibronectin isoform containing the ED-B oncofetal domain in normal human fibroblast cell lines originating from different tissues. Exp Cell Res 1992;199:98-105.
7. Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem 1992;267:24689-92.
8. Castellani P, Viale G, Dorcaratto A, Nicolò G, Kaczmarek J, Querzé G, et al. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis. Int J Cancer 1994;59:612-8.
9. Kaczmarek J, Castellani P, Nicolò G, Spina B, Allemanni G, Zardi L. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic, and neoplastic human breast tissues. Int J Cancer 1994;58:11-6.
10. Ruoslahti E. Structure and biology of proteoglycans. Ann Cell Biol 1988;4:229-55.
11. Hynes RO. Fibronectins. New York: Springer-Verlag, Inc., 1990.
12. Castellani P, Siri A, Rosellini C, Infusini E, Borsi L, Zardi L. Transformed human cells release different fibronectin variants than do normal cells. J Cell Biol 1986;103:1671-7.
13. Borsi L, Carnemolla B, Castellani P, Rosellini C, Vecchio D, Allemanni G, et al. Monoclonal antibodies in the analysis of fibronectin isoforms generated by alternative splicing of mRNA precursors in normal and transformed human cells. J Cell Biol 1987;104:595-600.
14. Vartio T, Laitinen L, Narvanen O, Cutolo M, Thornell LE, Zardi L, et al. Differential expression of the ED sequence-containing form of cellular fibronectin in embryonic and adult human tissues. J Cell Sci 1987;88:419-30.
15. Oyama F, Hirohashi S, Shimosato Y, Titani K, Sekiguchi K. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tumors. J Biol Chem 1989;264:10331-4.
16. Liberatore M, Neri D, Neri G, Pini A, Iurilli AP, Ponzo F, et al. Efficient one-step direct labelling of recombinant antibodies with technetium-99m. Eur J Nucl Med 1995;22:1326-9.
17. Bicknell R, Harris AL. Mechanisms and therapeutic implications of angiogenesis. Curr Opin Oncol 1996;8:60-5.